FRONTIER CAPITAL MANAGEMENT CO LLC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 260 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.

Quarter-by-quarter ownership
FRONTIER CAPITAL MANAGEMENT CO LLC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,316,184
+211.2%
34,600
+458.7%
0.01%
+180.0%
Q3 2022$423,000
+54.4%
6,193
+2.2%
0.01%
+66.7%
Q2 2022$274,000
-65.3%
6,060
-61.0%
0.00%
-57.1%
Q1 2022$790,000
-86.5%
15,549
-87.4%
0.01%
-84.8%
Q4 2021$5,839,000
-35.8%
123,490
-55.2%
0.05%
-35.2%
Q3 2021$9,094,000
-18.9%
275,910
+55.4%
0.07%
-13.4%
Q2 2021$11,220,000177,5250.08%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders